Biofrontera Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on April 8, 2022
02 April 2022 - 4:00AM
Biofrontera
Inc. (Nasdaq: BFRI),
a biopharmaceutical company specializing in the commercialization
of dermatological products, announced today it will report
financial results for the three months and full year ended December
31, 2021 before the opening of the U.S. financial markets on
Friday, April 8, 2022 and will host a conference call that same day
beginning at 11:00 a.m. Eastern time to discuss those results,
provide a business update and answer questions.
Conference Call and Webcast
Information
Event: |
Biofrontera Inc. Fourth Quarter and Full Year 2021 Financial
Results and Business Update Conference Call |
Date: |
Friday, April 8, 2022 |
Time: |
11:00 a.m. Eastern time |
Conference call: |
1-877-877-1275 (U.S.)1-412-858-5202 (international) |
Webcast: |
Live and 90-day replay webcast are available here and at
www.investors.biofrontera-us.com. |
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based
biopharmaceutical company commercializing a portfolio of
pharmaceutical products for the treatment of dermatological
conditions with a focus on PDT and topical antibiotics. The
Company’s licensed products are used for the treatment of actinic
keratoses, which are pre-cancerous skin lesions, as well as
impetigo, a bacterial skin infection. For more information, visit
https://www.biofrontera-us.com.
Contacts
Biofrontera Inc.Anke zur
Mühlen+1 781 486 1539us-ir@biofrontera.com
LHA Investor RelationsTirth T.
Patel+1 212 201 6614tpatel@lhai.com
Biofrontera (NASDAQ:BFRIW)
Historical Stock Chart
From Sep 2024 to Oct 2024
Biofrontera (NASDAQ:BFRIW)
Historical Stock Chart
From Oct 2023 to Oct 2024